Personalized Medicine in Benefit:Risk Assessment
*Scott Evans, Harvard University Keywords: Methods for personalized/tailored medicine using within-patient analyses of benefits and risks will be discussed. The methods allow for high order interactions in defining subgroups, control error rates for global and subgroup-specific inference, and account for the censoring and competing risk issues associated with benefit and risk events. Incorporating patient preference and weighting outcomes will be discussed. Ideas for improved design, monitoring, analyses, and reporting of benefits and risks will be high-lighted.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC